From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,208,292 shares, representing 3.11% for $19 million under the buyback announced on March 22, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | -1.76% | -3.59% | -10.41% |
06-05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
05-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.41% | 1.78B | |
+0.85% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+74.71% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Tranche Update on Catalyst Pharmaceuticals, Inc.'s Equity Buyback Plan announced on March 22, 2021.